We've spent an immense amount of time building Plasma One from scratch and we are grateful to document a few key moments of our build. This series, like our product, was a labor of love from our team to our users and the broader market. Plasma One, iA. 🕊️🤍

Trying the Stronger supplement. Pairing it with their NAD, and sermorelin shots. $ENHA

Extremely excited for @Plasma One to finally launch - and, admittedly, for me to get my Platinum Card. 😉 Stablecoins are already settling trillions of dollars in value. As a financial asset class, they've clearly won. What was still missing was the ability to use them seamlessly in everyday life. With Plasma One, that changes. Save, earn, and spend digital dollars (with more currencies coming soon) from anywhere in the world. Earn yield on your balances, use a cashback card that works in 150 countries, and move effortlessly between crypto and traditional financial rails. Plasma One is more than a product. It's the bank account for the digital age.

If you believe AI will dramatically reduce the need for human labor, one conclusion seems obvious: Own the things people will do with their free time. Sports. Live entertainment. Hospitality. Experiences. As work becomes less central to life, companies that create meaningful ways for people to play, connect, compete, and belong could become some of the biggest winners. $ENHA

This week's Interesting Times is a conversation with Christian Angermayer about (deep breath) "human-maxxing," the Enhanced Games, Ozempic for everything, biohacking and life extension and whether you meet God or demons on ayahuasca: youtube.com/watch?v=z8PPzQYZ…

Delighted to share our latest article, The Challenge of Commercialising Psychedelic Medicines, in the Summer 2026 edition of @EBRmagazine. Written by our Chief Medical Officer, Dr Kevin Craig, the article explores the path to clinical adoption for psychedelics in mental health - covering scalability, real-world delivery, and next-gen approaches bridging innovation with practical care. Read the piece here (pages 53 - 55): calameo.com/read/006113385f2…

“Better Sex, Better Hair, Better Sleep: ‘Humanmaxxing’ Is Here” If this headline didn’t catch your attention, I’m not sure what would 😉 I had a great podcast conversation with @DouthatNYT about all things enhancement. Unsurprisingly, the discussion also touched on $ENHA, $ATAI and the future of psychedelics, among many other fascinating topics. We ended on perhaps the biggest question of all - one that is as philosophical and even religious as it is scientific: As humans gain the ability to enhance themselves in ever more profound ways, are we actually meant to do so? And is there a point at which enhancement makes us less human rather than more? Check it out: nytimes.com/2026/06/11/opini…

Better sleep = faster times. The data proves it. After starting protocol, @Megan__Romano's sleep score peaked at 77. Right on cue, her time trials plummeted - shattering a 13-year-old personal best and dropping all the way to 24.5 seconds by the Enhanced Games. This is the story of an athlete optimizing in real time. Build your protocol at enhanced.com

The FDA's peptide meeting is scheduled for July 23–24, 2026. Many industry participants expect the agency to ease restrictions on several peptides that are currently unavailable for compounding and move them into the "allowed for compounding" category. Already today, @enhanced_games's telehealth platform, Live Enhanced, offers FDA-approved peptides such as Sermorelin and GLP-1s, compounded by U.S. pharmacies and prescribed by licensed U.S. physicians to U.S. consumers. As additional peptides become available, Live Enhanced intends to expand its offering accordingly. Analysts are increasingly viewing non-GLP-1 peptides as a major future category. Needless to mention that GLP-1s – so all the weight loss drugs, which are peptides as well – are the biggest business in healthcare already. Axios recently cited industry estimates suggesting the broader peptide market is already worth approximately $60 billion – EX GLP-1s ! - and could potentially triple as regulation evolves and adoption expands. I believe Enhanced is uniquely positioned to capitalize on this trend. The key question investors should ask themselves is simple: Which brand will consumers trust when it comes to human enhancement? I believe consumers will trust the brand that can demonstrate - credibly, scientifically, and transparently - how enhancement products can be used safely and effectively through regulated, physician-supervised protocols. Enhanced has something no other telehealth platform has: elite athletes publicly demonstrating the power of optimization, recovery, longevity, and performance enhancement in real time. I believe consumers will see those results and increasingly seek to apply similar tools to their own lives. Because enhancement is not just for elite athletes - it is relevant for everyone. In short, I believe consumers will trust the Enhanced brand. July 23–24, 2026, will be a major inflection point for $ENHA

Peptide meeting is coming, and companies that will benefit haven’t even started to run yet. The main peptides that will be discussed are BPC157, KPV, TB500, MOTSc, Emildeltide, Semax, and Epitalon. $HIMS $ENHA

You read it in my $ENHA blog post first. Nice to see other investors starting to connect the dots as well. “The antithesis of AI is all sports, and for every moment that AI is going to take over and the agents are going to rule the world, you are left with craving live events and entertainment,” Mary Callahan Erdoes, head of JPMorgan Chase’s asset and wealth management division, at the @Forbes Iconoclast Summit

The flywheel is working. The @enhanced_games reached more than 1 billion people globally, generated nearly 4,000 media mentions, and increased Enhanced's owned-media audience by 884%. Most importantly, that attention is now translating into measurable results for $ENHA's Live Enhanced telehealth platform, with significantly improved marketing efficiency and customer acquisition economics. This is direct evidence of the flywheel between the sports and consumer health businesses. Read more in the company's latest update: investors.enhanced.com/enhan…

There were 21 total Personal Bests at the 2026 Enhanced Games, including 2 each from Kristian Gkolomeev, Emily Barclay, and Ben Proud. Get enhanced. Learn more at enhanced.com.

Because we are the good guys. The moment the IOC started treating its athletes like props only, and denying them their fair share, they started to erode the very social fabric that makes sport meaningful. At the @enhanced_games , we take a different approach. We are one big family. We genuinely care about our athletes - not just in words, but through our actions. That includes rewarding them with life-changing salaries and prize money and giving them the respect and support they deserve. And some of them have even become shareholders in $ENHA I can confirm what Hunter said: since the event, some of the biggest names in swimming - and increasingly in track & field - have reached out and entered conversations with us after seeing that we can deliver on our vision. The momentum behind the Enhanced Games is very real. We have crossed an important threshold, and I have no doubt that we will be welcoming several truly high-profile athletes to the roster in the very near future.

At 35, Megan Romano beat the personal best she set at 22. 13 years between bests. That isn't how aging is supposed to work. Build your protocol at enhanced.com.

Scenes from Kristian Gkolomeev's $1,000,000 World Record swim ⚡️

Dylan Cooper added 15kg (33lbs) to his Clean & Jerk at age 29. Three years after his previous best. In strength sports, 1kg is a win. Build your protocol at enhanced.com.

Being the best version of yourself - a mantra we promote at Enhanced Group and through the @enhanced_games - is not just about performance or appearance. First and foremost, it's about health. Being fit rather than overweight doesn't just improve how you look. Growing evidence suggests it can significantly improve long-term health outcomes. For example, recent studies have shown that GLP-1 agonists, such as semaglutide and tirzepatide, are associated with a substantially lower risk of several cancers. And it gets even more interesting: there are also indications that GLP-1s may slow certain biological aging markers, independent of their effects on weight loss. That's why GLP-1 therapies are a core offering on $ENHA 's "Live Enhanced" telehealth platform. Looking better is nice. Living longer, reducing disease risk, and potentially slowing aspects of aging at the same time is even better. That's the real promise of GLP-1s. Check it out: enhanced.com/live-enhanced

AI compute is the future. Rumble is now meaningfully executing on that vision.